Heron Therapeutics
HRTX
#8263
Rank
A$0.24 B
Marketcap
$1.63
Share price
-5.36%
Change (1 day)
-18.27%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.39 Billion

According to Heron Therapeutics's latest financial reports the company's total liabilities are A$0.39 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.37 B7.92%
2022-12-31A$0.34 B10.85%
2021-12-31A$0.31 B106.7%
2020-12-31A$0.15 B-2.16%
2019-12-31A$0.15 B19.13%
2018-12-31A$0.13 B-1.16%
2017-12-31A$0.13 B7.35%
2016-12-31A$0.12 B354.4%
2015-12-31A$27.09 M62.78%
2014-12-31A$16.64 M112.31%
2013-12-31A$7.83 M96.1%
2012-12-31A$3.99 M10.98%
2011-12-31A$3.6 M129.37%
2010-12-31A$1.57 M-34.55%
2009-12-31A$2.39 M-59.72%
2008-12-31A$5.95 M-30.35%
2007-12-31A$8.55 M29.83%
2006-12-31A$6.58 M74.23%
2005-12-31A$3.78 M2.28%
2004-12-31A$3.69 M45.2%
2003-12-31A$2.54 M-38.24%
2002-12-31A$4.12 M-51.48%
2001-12-31A$8.49 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.32 B 237.08%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$1.18 B 201.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.40 B 2.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-64.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$91.26 M-76.85%๐Ÿ‡บ๐Ÿ‡ธ USA